Using Due Diligence to Prepare for Uncertainty

Using Due Diligence to Prepare for Uncertainty

October 2, 2017
October 2, 2017

Share

Deals have become increasingly competitive, with an ever-increasing number of bidders involved in every transaction. The temptation arises to cut corners when evaluating deals, focusing on a narrow and select set of areas to validate and justify closing the transaction and only addressing other areas if the deal closes. Stax leaders Paul Edwards and Romero Hayman share why such an approach is short-sighted — and carries significant risk.


Part 1:


Part 2:

Read More

Grant Thornton Stax Advises Thoma Bravo on Merger of Hypergene & Stratsys
December 19, 2025
Grant Thornton Stax recently supported Hypergene, a portfolio management solutions backed by Thoma Bravo, on its recent merger with Stratsys. Read about the deal here.
Grant Thornton Stax Community ERG Unites to Give Back
December 17, 2025
Our teams across the US offered to spread some holiday cheer, rallying together to donate toys to local charities. Read about our various efforts, as well as charities you can donate to.
Grant Thornton Stax Sell-side: Pairsoft Investment by TA Assoc.
December 17, 2025
Grant Thornton Stax supported Pairsoft, a leading provider of procure-to-pay automation and payment solutions, on its recent majority growth investment by TA Associates. Read more.
Grant Thornton Stax Sell-side Support: Moss Acquisition by Vomela
December 17, 2025
Grant Thornton Stax recently supported Moss, a global producer of innovative brand experiences, on its acquisition by Vomela, a Riverside Company. Read more about the deal here
Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Show More